NEXGEL (NASDAQ:NXGL) Issues Quarterly Earnings Results

NEXGEL (NASDAQ:NXGLGet Free Report) posted its earnings results on Monday. The company reported ($0.08) EPS for the quarter, Zacks reports. NEXGEL had a negative net margin of 52.60% and a negative return on equity of 71.19%.

NEXGEL Stock Up 14.4 %

NXGL stock traded up $0.39 during trading on Monday, hitting $3.09. 74,673 shares of the company’s stock traded hands, compared to its average volume of 64,378. The business has a fifty day simple moving average of $3.24 and a two-hundred day simple moving average of $3.27. The company has a quick ratio of 0.93, a current ratio of 1.51 and a debt-to-equity ratio of 0.19. The firm has a market capitalization of $20.98 million, a P/E ratio of -5.33 and a beta of 0.62. NEXGEL has a 1 year low of $1.84 and a 1 year high of $5.10.

NEXGEL Company Profile

(Get Free Report)

NEXGEL, Inc manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc and changed its name to NEXGEL, Inc in November 2019.

Read More

Earnings History for NEXGEL (NASDAQ:NXGL)

Receive News & Ratings for NEXGEL Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NEXGEL and related companies with MarketBeat.com's FREE daily email newsletter.